Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.34B | 8.68B | 9.72B | 10.40B | 8.01B | 8.83B |
Gross Profit | 9.14B | 0.00 | 9.72B | 10.40B | 8.01B | 8.83B |
EBITDA | 947.00M | 478.00M | 0.00 | 2.01B | 0.00 | 1.53B |
Net Income | 433.00M | 954.00M | 632.00M | 972.00M | 333.00M | 559.00M |
Balance Sheet | ||||||
Total Assets | 560.50B | 548.42B | 552.20B | 551.29B | 569.87B | 552.49B |
Cash, Cash Equivalents and Short-Term Investments | 34.13B | 0.00 | 33.31B | 30.16B | 36.79B | 40.12B |
Total Debt | 1.39B | 11.56B | 18.27B | 18.73B | 35.23B | 25.38B |
Total Liabilities | 531.12B | 519.07B | 520.89B | 5.23B | 537.55B | 518.90B |
Stockholders Equity | 28.50B | 28.45B | 30.43B | 29.40B | 31.48B | 32.79B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.35B | 2.18B | -19.88B | 11.13B | 11.56B |
Operating Cash Flow | 0.00 | 1.65B | 2.64B | -19.22B | 11.28B | 11.69B |
Investing Cash Flow | 0.00 | -2.09B | 972.00M | 13.79B | -13.30B | -19.21B |
Financing Cash Flow | 0.00 | -2.19B | -272.00M | -272.00M | -341.00M | -273.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $492.74B | 11.08 | 7.63% | 3.96% | -1.55% | 45.42% | |
73 Outperform | $973.27B | 13.07 | 6.30% | 3.23% | 9.27% | 20.49% | |
71 Outperform | ¥358.61B | 9.38 | 1.37% | 21.04% | 20.47% | ||
70 Outperform | ¥776.20B | 10.60 | 7.30% | 3.46% | 15.35% | -1.62% | |
68 Neutral | ¥65.41B | 6.80 | 2.82% | 17.59% | 44.54% | ||
68 Neutral | ¥724.27B | 10.74 | 7.55% | 3.29% | 7.97% | 15.90% | |
61 Neutral | ¥8.30B | 8.61 | 3.28% | -10.59% | -44.94% |